To include your compound in the COVID-19 Resource Center, submit it here.

Setrobuvir: Completed Phase IIb enrollment

Anadys disclosed in its 2Q11 earnings that the company completed enrollment of about 275 treatment-naïve and treatment-experienced

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE